Evommune, Inc.
EVMN
$24.09
-$0.94-3.76%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -68.87M | -61.32M | -64.76M | -78.58M | -66.81M |
| Total Depreciation and Amortization | 1.39M | 1.42M | 1.44M | 1.39M | 1.29M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.84M | -8.40M | -8.38M | 307.00K | -98.00K |
| Change in Net Operating Assets | -4.12M | -9.95M | -23.15M | -383.00K | 7.42M |
| Cash from Operations | -76.44M | -78.25M | -94.85M | -77.26M | -58.20M |
| Capital Expenditure | -235.00K | -131.00K | 0.00 | -18.00K | -88.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -115.07M | -25.36M | 7.83M | -123.00K | -3.91M |
| Cash from Investing | -115.31M | -25.49M | 7.83M | -141.00K | -3.99M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -531.00K | -584.00K | -562.00K | -515.00K | -423.00K |
| Issuance of Common Stock | 157.29M | 17.00K | 17.00K | 13.00K | 13.00K |
| Repurchase of Common Stock | -1.22M | -- | -- | -- | -- |
| Issuance of Preferred Stock | 65.23M | 115.06M | 115.06M | 49.83M | 49.83M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -874.00K | -736.00K | -- | -- |
| Cash from Financing | 220.76M | 113.62M | 113.78M | 49.33M | 49.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 29.02M | 9.88M | 26.76M | -28.08M | -12.77M |